Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: E
Results 1 - 10 of 338 shown below

  • E-cadherin

    W Jiao, K Miyazaki and Y Kitajima

    Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo

    doi:10.1038/sj.bjc.6600017

  • J-L Ku, K-A Yoon, I-J Kim, W-H Kim, J-Y Jang, K-S Suh, S-W Kim, Y-H Park, J-H Hwang, Y-B Yoon and J-G Park

    Establishment and characterisation of six human biliary tract cancer cell lines

    doi:10.1038/sj.bjc.6600440

  • J J French, J Cresswell, W K Wong, K Seymour, R M Charnley and J A Kirby

    T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?

    doi:10.1038/sj.bjc.6600597

  • K B Pedersen, J M Nesland, Ø Fodstad and G M Mælandsmo

    Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies

    doi:10.1038/sj.bjc.6600624

  • C G Colpaert, P B Vermeulen, I Benoy, A Soubry, F Van Roy, P van Beest, G Goovaerts, L Y Dirix, P Van Dam, S B Fox, A L Harris and E A Van Marck

    Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression

    doi:10.1038/sj.bjc.6600807

  • T Nakashima, C Huang, D Liu, K Kameyama, D Masuya, S Kobayashi, M Kinoshita and H Yokomise

    Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

    doi:10.1038/sj.bjc.6600955

  • N Tanaka, T Odajima, K Ogi, T Ikeda and M Satoh

    Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma

    doi:10.1038/sj.bjc.6601124

  • G Ronzitti, F Callegari, C Malaguti and G P Rossini

    Selective disruption of the E-cadherin–catenin system by an algal toxin

    doi:10.1038/sj.bjc.6601640

  • M J Larriba and A Muñoz

    SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications

    advance online publication, 2005-03-15 00:00:00.000;

    doi:10.1038/sj.bjc.6602484

  • R Kuefer, M D Hofer, C S M Zorn, O Engel, B G Volkmer, M A Juarez-Brito, M Eggel, J E Gschwend, M A Rubin and M L Day

    Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602599

  • N Bhagavathula, E A Kelley, M Reddy, K C Nerusu, C Leonard, K Fay, S Chakrabarty and J Varani

    Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma

    advance online publication, 2005-11-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602852

  • A Batistatou, C D Scopa, P Ravazoula, Y Nakanishi, D Peschos, N J Agnantis, S Hirohashi and K A Charalabopoulos

    Involvement of dysadherin and E-cadherin in the development of testicular tumours

    doi:10.1038/sj.bjc.6602880

  • M Lombaerts, T van Wezel, K Philippo, J W F Dierssen, R M E Zimmerman, J Oosting, R van Eijk, P H Eilers, B van de Water, C J Cornelisse and A-M Cleton-Jansen

    E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines

    advance online publication, 2006-02-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602996

  • D Krubasik, N G Iyer, W R English, A A Ahmed, M Vias, C Roskelley, J D Brenton, C Caldas and G Murphy

    Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition

    advance online publication, 2006-04-18 00:00:00.000;

    doi:10.1038/sj.bjc.6603101

  • M Shioiri, T Shida, K Koda, K Oda, K Seike, M Nishimura, S Takano and M Miyazaki

    Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

    doi:10.1038/sj.bjc.6603193

  • A Batistatou, D Peschos, H Tsanou, A Charalabopoulos, Y Nakanishi, S Hirohashi, N J Agnantis and K Charalabopoulos

    In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin

    advance online publication, 2007-04-17 00:00:00.000;

    doi:10.1038/sj.bjc.6603743

  • K L Sodek, M J Ringuette and T J Brown

    MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells

    advance online publication, 2007-07-03 00:00:00.000;

    doi:10.1038/sj.bjc.6603863

  • K Blechschmidt, S Sassen, B Schmalfeldt, T Schuster, H Höfler and K-F Becker

    The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients

    advance online publication, 2007-11-20 00:00:00.000;

    doi:10.1038/sj.bjc.6604115

  • W N Yap, P N Chang, H Y Han, D T W Lee, M T Ling, Y C Wong and Y L Yap

    italic gamma-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways

    advance online publication, 2008-11-11 00:00:00.000;

    doi:10.1038/sj.bjc.6604763

  • N Morita, H Uemura, K Tsumatani, M Cho, Y Hirao, E Okajima, N Konishi and Y Hiasa

    E-cadherin and alpha-, beta- and bold gamma-catenin expression in prostate cancers: correlation with tumour invasion

    doi:10.1038/sj.bjc.6690299

  • A S Protheroe, R E Banks, M Mzimba, W H Porter, J Southgate, P N Singh, M Bosomworth, P Harnden, P H Smith, P Whelan and P J Selby

    Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer

    doi:10.1038/sj.bjc.6690351

  • Y Shimada, M Imamura, G Watanabe, S Uchida, H Harada, T Makino and M Kano

    Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology

    doi:10.1038/sj.bjc.6690499

  • B P L Wijnhoven, N J de Both, H van Dekken, H W Tilanus and W N M Dinjens

    E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus

    doi:10.1038/sj.bjc.6690577

  • C Huiping, J R Sigurgeirsdottir, J G Jonasson, G Eiriksdottir, J T Johannsdottir, V Egilsson and S Ingvarsson

    Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer

    doi:10.1038/sj.bjc.6690815

  • M Barshishat, S Polak-Charcon and B Schwartz

    Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells

    doi:10.1054/bjoc.1999.0899

  • Z Popov, S Gil-Diez de Medina, M-A Lefrere-Belda, A Hoznek, S Bastuji-Garin, C C Abbou, J P Thiery, F Radvanyi and D K Chopin

    Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information

    doi:10.1054/bjoc.2000.1233

  • S Miyamoto, H Baba, S Kuroda, K Kaibuchi, T Fukuda, Y Maehara and T Saito

    Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer

    doi:10.1054/bjoc.2000.1386

  • I EI-Hariry, M Pignatelli and N R Lemoine

    FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines

    doi:10.1054/bjoc.2001.1813

  • E-cadherin mutations

    J Stone, S Bevan, D Cunningham, A Hill, N Rahman, J Peto, A Marossy and R S Houlston

    Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer

    doi:10.1038/sj.bjc.6690308

  • N Rahman, J G Stone, G Coleman, B Gusterson, S Seal, A Marossy, S R Lakhani, A Ward, A Nash, A McKinna, R A'Hern, M R Stratton and R S Houlston

    Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene

    doi:10.1054/bjoc.1999.0965

  • E-selectin

    C-M Liu, T-S Sheen, J-Y Ko and C-T Shun

    Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer

    doi:10.1038/sj.bjc.6690057

  • M Martín-Satué, C de Castellarnau and J Blanco

    Overexpression of alpha(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells

    doi:10.1038/sj.bjc.6690482

  • E. tirucalli

    A MacNeil, O P Sumba, M L Lutzke, A Moormann and R Rochford

    Activation of the Epstein–Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli

    doi:10.1038/sj.bjc.6600929

  • E1B-deleted

    J-L Hsieh, C-L Wu, M-D Lai, C-H Lee, C-S Tsai and A-L Shiau

    Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1–5

    doi:10.1038/sj.bjc.6600908

  • E2F

    M Mousli, R Hopfner, A-Q Abbady, D Monté, M Jeanblanc, P Oudet, B Louis and C Bronner

    ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells

    doi:10.1038/sj.bjc.6601068

  • B G Le François, J A Maroun and H C Birnboim

    Expression of thymidylate synthase in human cells is an early G1 event regulated by CDK4 and p16INK4A but not E2F

    advance online publication, 2007-10-09 00:00:00.000;

    doi:10.1038/sj.bjc.6604020

  • E6

    M Kuroda, T Kiyono, K Oikawa, K Yoshida and K Mukai

    The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target

    advance online publication, 2005-01-11 00:00:00.000;

    doi:10.1038/sj.bjc.6602329

  • E6 gene, polymorphism

    S Andersson, M Alemi, E Rylander, A Strand, B Larsson, J Sällström and E Wilander

    Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions

    doi:10.1054/bjoc.2000.1247

  • E6 oncogene

    C Kämmer, M Tommasino, S Syrjänen, H Delius, U Hebling, U Warthorst, H Pfister and I Zehbe

    Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease

    doi:10.1038/sj.bjc.6600024

  • E6/E7 oncogenes

    M S caronmahel, E Sobotková, J Bubeník, J S caronímová, R Z caronák, V Ludvíková, R Hájková, J Kovar caroník, F Jelínek, C Povýs caronil, J Marinov and V Vonka

    Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16

    doi:10.1054/bjoc.2000.1615